EyeGate Pharmaceuticals Appoints Eric J. Daniels, MD, MBA, as Chief Development Officer and Closes Acquisition of Bayon Therapeutics, Inc.
Stock Information for AB Corporate Bond ETF
Loading
Please wait while we load your information from QuoteMedia.